Your browser doesn't support javascript.
loading
The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease.
Cronin, Robert M; Lin, Chyongchiou J; Chiang, ChienWei; MacEwan, Sarah R; DeBaun, Michael R; Hyer, J Madison.
Afiliación
  • Cronin RM; Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Lin CJ; College of Nursing, The Ohio State University, Columbus, OH.
  • Chiang C; Department of Biomedical Informatics, The Ohio State University, Columbus, OH.
  • MacEwan SR; Secondary Data Core, The Ohio State University, Columbus, OH.
  • DeBaun MR; Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Hyer JM; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Blood Adv ; 7(13): 3114-3116, 2023 07 11.
Article en En | MEDLINE | ID: mdl-36883847
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anemia de Células Falciformes Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anemia de Células Falciformes Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article